BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Prognosis
22 results:

  • 1. Should the breast cancer Staging System be Revised?
    Sanli AN; Tekcan Sanli DE; Aydogan F; Altundag MK
    Am Surg; 2024 May; 90(5):1066-1073. PubMed ID: 38128067
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Preoperative Radiotherapy Does Not Change the Existing Treatment Paradigm in Stage III breast cancer.
    He Y; Chen Q; Zhu F; Liu C; Shao Y; Liu H
    Oncology; 2024; 102(4):310-317. PubMed ID: 37748458
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The characteristics and survival of second primary lung cancer after Hodgkin's lymphoma: A comparison with first primary lung cancer using the SEER database.
    Lin L; Wang D; Chen H
    PLoS One; 2023; 18(5):e0285766. PubMed ID: 37195975
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Survival Nomogram for Patients With Locally Advanced breast cancer Undergoing Immediate breast Reconstruction: A SEER Population-Based Study.
    Pan J; Peng L; Xia C; Wang A; Tong X; Chen X; Zhang J; Xu X
    Clin Breast Cancer; 2023 Jun; 23(4):e219-e229. PubMed ID: 36890005
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pathological complete response and prognosis after neoadjuvant chemotherapy in patients with HER2-low breast cancer.
    Qiao W; Guo W; Liu Q; Guo X; Deng M
    Ann Diagn Pathol; 2023 Jun; 64():152125. PubMed ID: 36822053
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]    [Full Text] [Related]  

  • 7. MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.
    Xiao Y; Zhang SJ; Yan X; Wu C; Liu QW; Dong HX; Wang LJ; Hu Y
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5625-5635. PubMed ID: 34604955
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma.
    Drake V; Bigelow E; Fakhry C; Windon M; Rooper LM; Ha P; Miles B; Gourin C; Mandal R; Mydlarz W; London N; Vosler PS; Yavvari S; Troy T; Waterboer T; Eisele DW; D'Souza G
    Oral Oncol; 2021 Oct; 121():105461. PubMed ID: 34304004
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term exposure to road traffic noise and incidence of breast cancer: a cohort study.
    Andersen ZJ; Jørgensen JT; Elsborg L; Lophaven SN; Backalarz C; Laursen JE; Pedersen TH; Simonsen MK; Bräuner EV; Lynge E
    Breast Cancer Res; 2018 Oct; 20(1):119. PubMed ID: 30290832
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type].
    Yue M; Li F; Deng HY; Zhang LL; Liu YP
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):754-758. PubMed ID: 29061019
    [No Abstract]    [Full Text] [Related]  

  • 11. Clinical and histopathological features of breast cancer in Jordan: Experience from a tertiary care hospital.
    Obeidat F; Ahram M; Al Khader A; Battah K; Alchalabi M; Melhem JM; Suleiman A
    J Pak Med Assoc; 2017 Aug; 67(8):1206-1212. PubMed ID: 28839305
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.
    Mao K; Liu J; Sun J; Zhang J; Chen J; Pawlik TM; Jacobs LK; Xiao Z; Wang J
    J Gastroenterol Hepatol; 2016 Feb; 31(2):417-26. PubMed ID: 26250532
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.
    Niikura N; Hayashi N; Masuda N; Takashima S; Nakamura R; Watanabe K; Kanbayashi C; Ishida M; Hozumi Y; Tsuneizumi M; Kondo N; Naito Y; Honda Y; Matsui A; Fujisawa T; Oshitanai R; Yasojima H; Tokuda Y; Saji S; Iwata H
    Breast Cancer Res Treat; 2014 Aug; 147(1):103-12. PubMed ID: 25106661
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology.
    Uyeturk U; Oksuzoglu B; Akman T; Turker I; Sener N; Tastekin D; Bal O; Berk V; Arslan UY; Urakci Z; Bilir C; Yilmaz U; Yazilitas D; Ulas A; Sonmez OU; Budakoglu B; Cihan S; Uysal M
    Med Oncol; 2014 Apr; 31(4):929. PubMed ID: 24659267
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data.
    Brouckaert O; Laenen A; Smeets A; Christiaens MR; Vergote I; Wildiers H; Moerman P; Floris G; Neven P;
    Breast; 2014 Aug; 23(4):371-7. PubMed ID: 24530094
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumour-related factors and prognosis in breast cancer detected by screening.
    Olsson A; Borgquist S; Butt S; Zackrisson S; Landberg G; Manjer J
    Br J Surg; 2012 Jan; 99(1):78-87. PubMed ID: 22068957
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
    Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. prognosis and gene expression profiling of 20q13-amplified breast cancers.
    Ginestier C; Cervera N; Finetti P; Esteyries S; Esterni B; Adélaïde J; Xerri L; Viens P; Jacquemier J; Charafe-Jauffret E; Chaffanet M; Birnbaum D; Bertucci F
    Clin Cancer Res; 2006 Aug; 12(15):4533-44. PubMed ID: 16899599
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Discrepancy between second and first opinion in surgical oncological patients.
    Mellink WA; Henzen-Logmans SC; Bongaerts AH; Ooijen BV; Rodenburg CJ; Wiggers TH
    Eur J Surg Oncol; 2006 Feb; 32(1):108-12. PubMed ID: 16303280
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Association of body composition and weight history with breast cancer prognostic markers: divergent pattern for Hispanic and non-Hispanic White women.
    Baumgartner KB; Hunt WC; Baumgartner RN; Crumley DD; Gilliland FD; McTiernan A; Bernstein L; Ballard-Barbash R
    Am J Epidemiol; 2004 Dec; 160(11):1087-97. PubMed ID: 15561988
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.